Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

114 trials

NCT06255210
Recruiting
Efficacy and Safety of Induction Chemotherapy for Olfactory Neuroblastoma (ESICON)
Phase 2 · China · 1 site
Registry update: 13 Feb 2024
NCT05770037
Recruiting
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers
Phase 2/3 · United Kingdom · 27 sites
Registry update: 24 Nov 2025
NCT05400603
Recruiting
Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma
Phase 1 · United States · 1 site
Registry update: 26 Dec 2025
NCT05192980
Recruiting
SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours
Not applicable · Switzerland, Czechia, France, Norway · 38 sites
Registry update: 22 Jul 2025
NCT06296732
Recruiting
Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification
Not applicable · Russia · 1 site
Registry update: 20 May 2024
NCT06057948
Recruiting
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
Phase 2 · United States · 7 sites
Registry update: 9 Nov 2026
NCT06000787
Recruiting
MCT for the Harvard/UCSF ROBIN Center
Not applicable · United States · 2 sites
Registry update: 1 Oct 2026
NCT06071897
Recruiting
Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma
Phase 3 · Russia · 1 site
Registry update: 10 Oct 2023
NCT05642455
Recruiting
SPEARHEAD-3 Pediatric Study
Phase 1/2 · United States · 10 sites
Registry update: 11 Aug 2026
2024-519089-32-02
Recruiting
TCRaß+CD19+ depleted haploidentical stem cell transplantation followed by immunotherapy in patients with relapsed/resistant high-risk neuroblastoma
Phase 2 · Italy · 1 site
Registry update: 31 Jan 2025
NCT06013618
Recruiting
Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
Phase 2 · China · 1 site
Registry update: 17 Jun 2025
NCT05890781
Recruiting
Engineering Immune Organoids to Study Pediatric Cancer
Not applicable · France · 2 sites
Registry update: 9 Feb 2026
NCT05701306
Recruiting
APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors
Phase 1/2 · China · 3 sites
Registry update: 21 Aug 2026
NCT05562024
Recruiting
TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma
Phase 1 · China · 2 sites
Registry update: 27 Feb 2023
NCT05608148
Recruiting
Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors
Phase 1 · Japan · 1 site
Registry update: 7 Aug 2026
NCT05489887
Recruiting
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Phase 2 · Brazil, Canada, Spain, United States · 26 sites
Registry update: 12 Aug 2026
NCT05135975
Recruiting
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Phase 2 · United States · 6 sites
Registry update: 12 Aug 2025
NCT07064746
Recruiting
Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis and Staging of Neuroblastoma
Not applicable · China · 1 site
Registry update: 21 Jul 2025
NCT04897321
Recruiting
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Phase 1 · United States · 1 site
Registry update: 19 May 2026
NCT05826158
Recruiting
18F-mFBG LAFOV PET/CT Compared to 123I-mIBG Scintigraphy SPECT/CT for Evaluation of Children With Neuroblastoma
Not applicable · Denmark · 1 site
Registry update: 15 Nov 2024

Ordered by registry start date. Freshness and sponsorship never change the order.